Skip to main content

Table 1 The correlations of COVID-19 cases and death with BCG coverage and incidence of TB

From: Correlation between immunity from BCG and the morbidity and mortality of COVID-19

 

COVID-19 cases per 100,000 population

COVID-19 deaths per 100,000 population

Cases

Total population

BCG coverage < 95%

BCG coverage ≥ 95%

Total population

BCG coverage < 95%

BCG coverage ≥ 95%

BCG coverage

0.136 (p = 0.091)

0–.064 (p = 0.588)

0.176 (p = 0.111)

0.061 (p = 0.447)

−0.057 (p = 0.629)

0.227 (p = 0.038)

Pulmonary TB – Bacteriologically confirmed

−0.687 (p < 0.0005)

−0.556 (p < 0.0005)

− 0.591 (p < 0.0005)

−0.570 (p < 0.0005)

− 0.574 (p < 0.0005)

−0.333 (p = 0.002)

Pulmonary TB – Clinically confirmed

−0.699 (p < 0.0005)

−0.674 (p < 0.0005)

− 0.567 (p < 0.0005)

−0.516 (p < 0.0005)

− 0.639 (p < 0.0005)

−0.246 (p = 0.0026)

Extra-pulmonary TB

−0.652 (p < 0.0005)

−0.626 (p < 0.0005)

− 0.537 (p < 0.0005)

−0.541 (p < 0.0005)

− 0.607 (p < 0.0005)

−0.314 (p = 0.004)

Overall TB incidence

−0.743 (p < 0.0005)

−0.644 (p < 0.0005)

− 0.663 (p < 0.0005)

−0.611 (p < 0.0005)

− 0.645 (p < 0.0005)

−0.379 (p < 0.0005)

TB incidence in 15–64-year group

−0.742 (p < 0.0005)

− 0.649 (p < 0.0005)

−0.677 (p < 0.0005)

− 0.621 (p < 0.0005)

−0.646 (p < 0.0005)

− 0.405 (p < 0.0005)

TB incidence in > 65-year group

− 0.785 (p < 0.0005)

− 0.701 (p < 0.0005)

−0.697 (p < 0.0005)

− 0.647 (p < 0.0005)

−0.704 (p < 0.0005)

− 0.382 (p < 0.0005)

  1. BCG Bacillus Calmette–Guérin vaccine
  2. TB Tuberculosis